Effectiveness of Individualized Exercise Program, Combined With a Balanced Diet on the Evolution of Body Fat (LIPOXmax-RUN)
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The purpose of this study is to evaluate the efficacy of 3 of physical exercise training programs, with a supplementation in fruits and vegetables, on body composition. 126 women will be randomized into 3 groups (42 subjects per group). The first program will be conducted at a relatively low intensity of effort, corresponding to the maximum rate of lipid oxidation (LIPOXmax)measured by indirect calorimetry. The second program will be at 60% of VO2peak and the third program will be prescribed according to the Good Practices physical Guidelines (30 minutes per day at a moderate intensity). All subjects will receive a free supplement of 5 fruits and vegetables per day during all the intervention. The intervention will last 5 months in total.
| Condition | Intervention |
|---|---|
|
Obesity |
Behavioral: LIPOXmax Behavioral: 60% VO2peak Behavioral: Good Medical Practices Dietary Supplement: supplementation in fruits and vegetables |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Efficacy Study Intervention Model: Parallel Assignment Masking: Open Label Primary Purpose: Prevention |
| Official Title: | Evaluation of the Effectiveness of Individualized Exercise Program, Combined With a Balanced Diet Rich in Fruits and Vegetables, on the Evolution of Body Fat in Overweight or Obese Women, as Part of Type 2 Diabetes Prevention in Reunion Island. |
- body fat mass reduction [ Time Frame: change from baseline in body fat mass at 5 months ] [ Designated as safety issue: No ]body fat mass will be measured by Dual Energy X-ray absorptiometry (M0 and M5) and by impedencemetry (M0, M3, M5).
- oxydative stress and inflammatory status [ Time Frame: at the inclusion (M0), and at M3 and at the end of the study at M5 ] [ Designated as safety issue: No ]inflammatory status : TNF alpha, IL-6, Leptin and adiponectin oxydative stress : test Folin-Ciocalteu and test DPPH
- biological parameter [ Time Frame: M0, M3, M5 ] [ Designated as safety issue: No ]blood glucose
- quality of life [ Time Frame: M0, M3, M5 ] [ Designated as safety issue: No ]quality of life questionaire : Short-Form 36
- feasibility in population [ Time Frame: every two weeks ] [ Designated as safety issue: No ]
with questionaire about:
- the adherence (number of session of physical activity are completed)
- secondary effects of the physical exercise program (tiredness, joint pain)
- biological parameter [ Time Frame: M0, M3, M5 ] [ Designated as safety issue: No ]Hb1Ac
- biological parameter [ Time Frame: M0, M3, M5 ] [ Designated as safety issue: No ]insulinemia (µU/mL)
- biological parameter [ Time Frame: M0, M3, M5 ] [ Designated as safety issue: No ]total cholesterol
- biological parameter [ Time Frame: M0, M3, M5 ] [ Designated as safety issue: No ]HDL-C
- biological parameter [ Time Frame: M0, M3, M5 ] [ Designated as safety issue: No ]LDL-C
- biological parameter [ Time Frame: M0, M3, M5 ] [ Designated as safety issue: No ]triglyceride
| Enrollment: | 137 |
| Study Start Date: | November 2011 |
| Study Completion Date: | September 2012 |
| Primary Completion Date: | September 2012 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Active Comparator: arm 3 : Good Medical Practices
physical exercise at home monitored by telephone (achieving a minimum of 30 minutes per day)
|
Behavioral: Good Medical Practices
Arm 3: The subjects initially receive the recommendations of good medical practice for physical activity (achieving at least 30min per day of "moderate" exercise).
Other Names:
Dietary Supplement: supplementation in fruits and vegetables
all groups will be supplemented in fruits and vegetables (5 per day) during all the study
Other Names:
|
|
Active Comparator: arm 2 : 60% VO2peak
physical exercise at the intensity of 60% of VO2 peak. 4 times a week. duration will be adjusted for arm 1 and arm 2 have the same total energy expenditure by session.
|
Behavioral: 60% VO2peak
Arm 2: physical activity standard arm (60% of VO2max measured by cardio respiratory exercise test). Subjects will realize 4 sessions per week and duration of sessions will be adjusted so that arms 1 and 2 have the same total energy expenditure by session.
Other Names:
Dietary Supplement: supplementation in fruits and vegetables
all groups will be supplemented in fruits and vegetables (5 per day) during all the study
Other Names:
|
|
Experimental: arm 1 : LIPOXmax
physical exercise at the LIPOXmax intensity during 60 minutes. 4 times a week
|
Behavioral: LIPOXmax
Arm 1: LIPOXmax arm. Subjects will perform a physical activity 4x1 hour per week at the optimal intensity for fat oxidation (LIPOXmax) measured by indirect calorimeter.
Other Names:
Dietary Supplement: supplementation in fruits and vegetables
all groups will be supplemented in fruits and vegetables (5 per day) during all the study
Other Names:
|
Show Detailed Description
Eligibility| Ages Eligible for Study: | 20 Years to 40 Years |
| Genders Eligible for Study: | Female |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- women
- 20-40 years old
- 27 ≤ BMI ≤40 kg / m²
- sedentary
- considered clinically stable
- able to rehabilitation training
- having signed an informed consent
- without professional activity
Exclusion Criteria:
- blood glucose ≥ 1.26 g / l
- HbA1c ≥ 6.5%
- severe hypertension (SBP ≥ 180 mmHg and / or DBP ≥ 110 mmHg)
- hypertension (≥140/90 mmHg) untreated or treated by beta blocker or calcium blocker
- absolute and relative contraindication to the maximal exercise test (ACC / AHA 2002) and / or physical training
- inability to achieve the maximum exercise test and / or the metabolic exercise test by indirect calorimeter
- uncompensated cardiovascular and / or respiratory disease revealed by exercise test
- pacemaker or defibrillator
- recent cardiovascular events (heart failure, treated by positive inotropic drugs, angioplasty within the last 10 days, cardiac surgery within the last 3 months, valvular disease requiring surgical correction, evolving myopericarditis, severe ventricular arrhythmias non stabilized under treatment)
- known and documented myopathy
- cancer
- acute and chronic inflammatory disease
- end stage renal disease
- digestive system operation
- treated by corticoids, thyroid hormone, antidepressant or neuroleptics
- pregnancy
- mental deficiency that prevents the understanding of informed consent and protocol
- participation to another research protocol
- attendance in the previous month to a program of rehabilitation training or a diet
- associated evolutionary disease causing significant impairment of general condition.
Contacts and Locations
More Information
No publications provided
| Responsible Party: | Centre Hospitalier Universitaire de la Réunion ( Centre Hospitalier Felix Guyon ) |
| ClinicalTrials.gov Identifier: | NCT01464073 History of Changes |
| Other Study ID Numbers: | LIPOXmax |
| Study First Received: | October 21, 2011 |
| Last Updated: | October 25, 2012 |
| Health Authority: | France: Committee for the Protection of Personnes |
Keywords provided by Centre Hospitalier Universitaire de la Réunion:
|
NIDDM obesity lifestyle intervention physical exercise |
diet LIPOXmax FATmax fat oxydation rate |
Additional relevant MeSH terms:
|
Obesity Overnutrition Nutrition Disorders |
Overweight Body Weight Signs and Symptoms |
ClinicalTrials.gov processed this record on May 19, 2013